Direxion FundsInverse EquityLABD · NYSE Arca

Direxion Daily S&P Biotech Bear 3X ETF (LABD)

Compare Leveraged & Inverse ETFs Compare with others

Price: $6.98; —30 Oct 2026
Assets: $138.4M; Total net assets
Expense ratio: 1.07%; Category 0.00%
Yield: 6.53%; Trailing distributions

1Y return: -74.8%-44.8%; Category -30.1%
3Y CAGR: -69.8%-32.1%; Category -37.6%
5Y CAGR: -48.1%-24.3%; Category -23.8%

Loading NAV history…

Direxion Daily S&P Biotech Bear 3X ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-0.7%	-24.5%	-53.0%	-66.1%	-74.8%	-69.8%	-48.1%	-58.4%	-55.3%
Inverse Equity average	13.6%	-8.9%	-18.8%	-31.3%	-30.1%	-37.6%	-23.8%	-29.4%	-37.1%
Difference	-14.3%	-15.7%	-34.1%	-34.9%	-44.8%	-32.1%	-24.3%	-29.0%	-18.2%

Holdings

This ETF publishes no holdings breakdown.

ETF details

Issuer: Direxion Funds
Category: Equity · Inverse Equity
Ticker: LABD
Exchange: NYSE Arca
Inception: 28 May 2015 (11.4 years)
Structure: Exchange Traded Fund
Expense ratio: 1.07% (category 0.00%)
Holdings turnover: 0%
Distribution yield: 6.53%
Beta, 3 years: -3.08
Total net assets: $138.4M

Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other inverse equity ETFs

Other ETFs in the Inverse Equity category.

Compare Leveraged & Inverse ETFs